Defunct Company
Total Trials
5
As Lead Sponsor
4
As Collaborator
1
Total Enrollment
263
NCT03078582
Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients
Phase: Phase 2
Role: Lead Sponsor
Start: Mar 8, 2017
Completion: Mar 28, 2018
NCT03030183
Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab
Start: Apr 17, 2017
NCT03315130
Safety and Efficacy Study of RA101495 in Subjects With Generalized Myasthenia Gravis
Start: Oct 11, 2017
Completion: Nov 19, 2020
NCT04025632
Safety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy
Start: Nov 7, 2019
Completion: Jun 14, 2021
NCT04436497
HEALEY ALS Platform Trial - Regimen A Zilucoplan
Phase: Phase 2/3
Role: Collaborator
Start: Jul 29, 2020
Completion: May 4, 2022